Marques, Jéssica H M <br/><br/>
Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.  [electronic resource] 

 -  Life sciences  Sep 2018 
 - 131-138 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2018.07.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inducing Agents--chemistry<br/>Animals<br/>Antioxidants--pharmacology<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor--genetics<br/>Cell Proliferation--drug effects<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>In Vitro Techniques<br/>Melatonin--pharmacology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>MicroRNAs--genetics<br/>Neovascularization, Pathologic--prevention & control<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays